Marinus H J van Oers Selected Research

Marinus H J van Oers Research Topics

Disease

15	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 09/2004
8	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2017 - 11/2006
8	Multiple Myeloma 07/2015 - 02/2002
7	Infections 10/2015 - 06/2004
5	Neoplasms (Cancer) 06/2010 - 02/2002
4	Lymphoma (Lymphomas) 07/2015 - 09/2002
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2010 - 09/2002
3	Leukemia 07/2015 - 10/2007
2	Crohn Disease (Crohn's Disease) 12/2011 - 10/2011
2	Pathologic Complete Response 06/2010 - 01/2008
2	HIV Infections (HIV Infection) 01/2008 - 08/2005
2	Epstein-Barr Virus Infections 04/2006 - 08/2005
1	Neutropenia 10/2015
1	Mucositis 07/2014
1	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2014
1	Trisomy (Trisomies) 05/2014
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 02/2013
1	Acute Kidney Injury (Acute Renal Failure) 10/2011
1	Transfusion-Related Acute Lung Injury 02/2010
1	Multiple Organ Failure (MODS) 02/2010
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2009
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2009
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2008
1	Myocarditis (Carditis) 12/2007
1	Necrosis 06/2007
1	Disease Progression 06/2007
1	Inflammation (Inflammations) 11/2006
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2005
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2004
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 04/2004
1	Autoimmune Diseases (Autoimmune Disease) 09/2002
1	Carcinogenesis 02/2002

Drug/Important Bio-Agent (IBA)

10	Rituximab (Mabthera)FDA Link 01/2019 - 09/2002
4	Monoclonal AntibodiesIBA 05/2014 - 09/2002
4	LigandsIBA 12/2013 - 06/2004
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 03/2003
3	AntigensIBA 11/2005 - 09/2002
2	fludarabineIBA 01/2019 - 01/2014
2	Lenalidomide (CC 5013)FDA Link 01/2019 - 04/2010
2	ofatumumab FDA Link 10/2015 - 02/2008
2	Dasatinib (BMS 354825)FDA Link 01/2014 - 12/2008
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2010 - 03/2003
2	Vincristine (Oncovin)FDA LinkGeneric 05/2010 - 03/2003
2	DNA (Deoxyribonucleic Acid)IBA 01/2008 - 08/2005
2	Thalidomide (Thalomid)FDA Link 01/2008 - 04/2006
2	Melphalan (Alkeran)FDA LinkGeneric 07/2007 - 03/2003
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 09/2004 - 06/2004
1	Chlorambucil (Leukeran)FDA Link 01/2019
1	Indicators and Reagents (Reagents)IBA 10/2017
1	venetoclaxIBA 08/2015
1	AntibodiesIBA 08/2015
1	Phosphotransferases (Kinase)IBA 08/2015
1	PlatinumIBA 01/2015
1	Alemtuzumab (Campath)FDA Link 05/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2013
1	Complement System Proteins (Complement)IBA 02/2013
1	ABT-737IBA 01/2012
1	Azathioprine (Imuran)FDA LinkGeneric 10/2011
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 05/2010
1	Prednisone (Sone)FDA LinkGeneric 05/2010
1	Interleukin-6 (Interleukin 6)IBA 02/2010
1	Interleukin-10 (Interleukin 10)IBA 02/2010
1	Interleukin-12 (IL 12)IBA 02/2010
1	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2009
1	Imatinib Mesylate (Gleevec)FDA Link 12/2008
1	Yttrium-90IBA 11/2008
1	ibritumomab tiuxetan (Zevalin)FDA Link 11/2008
1	OligonucleotidesIBA 09/2008
1	EnzymesIBA 08/2008
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2007
1	VaccinesIBA 10/2007
1	CytokinesIBA 11/2006
1	Bortezomib (Velcade)FDA Link 04/2006
1	Epstein-Barr Virus Nuclear AntigensIBA 11/2005
1	Interferon-gamma (Interferon, gamma)IBA 11/2005
1	beta CateninIBA 04/2004
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2003
1	thiamine triphosphorate (TTP)IBA 03/2003
1	Syndecan-1 (Syndecan 1)IBA 02/2002
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2002
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 02/2002
1	Proteoglycans (Proteoglycan)IBA 02/2002
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 02/2002

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2023 - 03/2003
8	Therapeutics 01/2017 - 03/2003
5	Remission Induction 12/2011 - 03/2003
4	Hematopoietic Stem Cell Transplantation 07/2014 - 10/2007
4	Stem Cell Transplantation 02/2009 - 05/2003
1	Immunotherapy 01/2020
1	Consolidation Chemotherapy 07/2015
1	Induction Chemotherapy 07/2014
1	Chemoradiotherapy 07/2014
1	Length of Stay 12/2011
1	Transplantation 12/2011
1	Critical Care (Surgical Intensive Care) 02/2010
1	Retreatment 06/2007
1	Kidney Transplantation 04/2006
1	Highly Active Antiretroviral Therapy (HAART) 08/2005
1	Ligation 06/2004